Screener
Capricor Therapeutics CAPR Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| REVENUE / TOTAL REVENUE | Three Months Ended March 31, 2026 / — | Three Months Ended March 31, 2025 / — |
|---|---|---|
| Other income | 8,145 | 12,485 |
| Investment income | 2,904,506 | 729,542 |
| Loss on disposal of fixed assets | (81,143) | (150,673) |
| TOTAL OTHER INCOME (EXPENSE) | 2,831,508 | 591,354 |
| LOSS BEFORE INCOME TAXES | (33,941,345) | (24,391,594) |
| (Provision for) benefit from income taxes | — | — |
| NET LOSS | $(33,941,345) | $(24,391,594) |
| OTHER COMPREHENSIVE INCOME (LOSS) |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's other income (expense)?
- Capricor Therapeutics (CAPR) reported other income (expense) of $2.83M in Q1 2026.
- How has Capricor Therapeutics's other income (expense) changed year-over-year?
- Capricor Therapeutics's other income (expense) increased by 378.8% year-over-year, from $591.35K to $2.83M.
- What is the long-term trend for Capricor Therapeutics's other income (expense)?
- Over 3 years (2021 to 2024), Capricor Therapeutics's other income (expense) has grown at a 31.8% compound annual growth rate (CAGR), from $915.92K to $2.1M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Capricor Therapeutics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude